Combined strategies for enhancing the transdermal absorption of midazolam through human skin

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 9, 2010, Pages 1096-1102

  Balaguer Fernández, Cristina ^a   Femenía Font, Andrés ^a   Muedra, Vicente ^b   Merino, Virginia ^c   López Castellano, Alicia ^a  

^a UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^b HOSPITAL DE LA RIBERA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

chemical percutaneous enhancers; iontophoresis; midazolam; transdermal absorption

Indexed keywords

LAUROCAPRAM; MIDAZOLAM;

ARTICLE; CONTROLLED STUDY; DISK DIFFUSION; DRUG PENETRATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IONTOPHORESIS; SKIN ABSORPTION; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADULT; AZEPINES; BIOLOGICAL TRANSPORT; CHILD; DIFFUSION; FEMALE; HUMANS; IONTOPHORESIS; MIDAZOLAM; MIDDLE AGED; SKIN ABSORPTION;

EID: 77955264585     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2010.01142.x     Document Type: Article

References (35)

1. Kanto JH. Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anaesthesia. Pharmacotherapy 1985 5 : 138 155.
2. Olkkola KT, Ahonen J. Midazolam and other benzodiazepines. Handb Exp Phamacol 2008 182 : 335 360.
3. Kogan A et al. Premedication with midazolam in young children: a comparison of four routes of administration. Paediatr Anaesth 2002 12 : 685 689.
4. Wilton NCT et al. Preanesthetic sedation of preschool children using intranasal midazolam. Anesthesiol 1988 69 : 972 975.
5. Borland M et al. Procedural sedation in children in the emergency department: a predict study. Emerg Med Australas 2009 21 : 71 79.
6. Tanner T, Marks R. Delivering drugs by the transdermal route: review and comment. Skin Res Thecnol 2008 14 : 249 260.
7. Kasha PC, Banga AK. A review of patent literature for iontophoretic delivery and devices. Recent Pat Drug Deliv Formul 2008 2 : 41 50.
8. Sieg A et al. Electroosmosis in transdermal iontophoresis: implications for noninvasive and calibration-free glucose monitoring. Biophys J 2004 87 : 3344 3350. (Pubitemid 40468589)
9. Green PG et al. Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm Res 1991 8 : 1113 1120.
10. Turner NG et al. Iontophoresis of poly-L-lysines: the role of molecular weight? Pharm Res 1997 14 : 1322 1331. Erratum : Pharm Res 1998 15 : 504 507.
11. Leboulanger B et al. Reverse iontophoresis for non-invasive transdermal monitoring. Physiol Meas 2004 25 : 35 50.
12. Guy RH et al. Iontophoresis: electrorepulsion and electroosmosis. J Controlled Release 2000 64 : 129 132.
13. Merino V et al. Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm Res 1999 16 : 758 761.
14. Femenía-Font A et al. Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength. J Pharm Sci 2005 94 : 2183 2186.
15. Pikal MJ, Shah S. Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm Res 1990 7 : 118 126.
16. Pikal MJ, Shah S. Transport mechanisms in iontophoresis II. Electroosmotic flow and transference number measurements for hairless mouse skin. Pharm Res 1990 7 : 213 221.
17. Pikal MJ, Shah S. Transport mechanisms in iontophoresis III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm Res 1990 7 : 222 229.
18. Santi P, Guy RH. Reverse iontophoresis: parameters determining electroosmotic flow: I. pH and ionic strength. J Controlled Release 1996 38 : 159 165.
19. Santi P, Guy RH. Reverse iontophoresis: parameters determining electro-osmotic flow. II. Electrode chamber formulation. J Controlled Release 1996 42 : 29 36.
20. Semalty A et al. Iontophoretic drug delivery system: a review. Technol Health Care 2007 15 : 237 245.
21. Dixit N et al. Iontophoresis: an approach for controlled drug delivery: a review. Curr Dug Deliv 2007 4 : 1 10.
22. Merino V et al. Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis. J Pharm Pharmacol 2008 60 : 415 420.
23. Femenía-Font A et al. Combination strategies for enhancing transdermal absorption of sumatriptan through skin. Int J Pharm 2006 323 : 125 130.
24. Femenía-Font A et al. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur J Pharm Biopharm 2005 61 : 50 55.
25. Ahad A et al. Chemical penetraton enhancers: a patent review. Expert Opin Ther Patents 2009, 19 : 969 988.
26. Andersin R. Solubility and acid-base behaviour of midazolam in media of different pH, studied by ultraviolet spectrophotometry with multicomponent software. J Pharm Biomed Anal 1991 9 : 451 455.
27. Lawrence H et al. Oral midazolam preanesthetic medication in pediatric outpatients. Anaesthesiology 1990 73 : 831 834.
28. Walbergh EJ et al. Plasma concentrations of midazolam in children following intranasal administration. Anaesthesiology 1991 74 : 233 235.
29. Roelofse J et al. Preanesthetic medication with rectal midazolam in children undergoing dental extractions. J Oral Maxillofac Surg 1990 48 : 791 797.
30. Nishiyama T et al. The effects of age and gender on the optimal premedication dose of intramuscular midazolam. Anesth Analg 1998 86 : 1103 1108.
31. Heizmann P et al. Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol 1983 16 : 43 49.
32. Ota Y, et al. Evaluation of percutaneous absorption of midazolam by terpenes. Drug Metab Pharmacokin 2003 18 : 261 266.
33. Jenke DR. Chromatographic method validation: a review of current practices and procedures. I. Guidelines for primary validation parameters. J Liq Chromatogr Relat Technol 1996 19 : 719 736.
34. Jenke DR. Chromatographic method validation: a review of current practices and procedures. II. Guidelines for primary validation parameters. J Liq Chromatogr Relat Technol 1996 19 : 737 757.
35. Schwagmeier R et al. Midazolam pharmacokinetics following intravenous and buccal administration. Br J Clin Pharmacol 1998 46 : 203 206.